Assessment of the ability to predict complications of the Risk Factor Scale for Pre-eclampsia Complications and the fullPIERS scale in pregnant women in a Hospital in Lima, Peru.
Patricia N Aquino-Vásquez, Luis Gm Chuquipoma-Zanabria, Maria Lazo-Porras, Mónica Flores-Noriega
{"title":"Assessment of the ability to predict complications of the Risk Factor Scale for Pre-eclampsia Complications and the fullPIERS scale in pregnant women in a Hospital in Lima, Peru.","authors":"Patricia N Aquino-Vásquez, Luis Gm Chuquipoma-Zanabria, Maria Lazo-Porras, Mónica Flores-Noriega","doi":"10.17843/rpmesp.2025.421.14041","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives.: </strong>To evaluate the ability of the Risk Factor Scale for Preeclampsia Complications (RFSPC) and the fullPIERS (Pre-eclampsia Integrated Estimate of RiSk) scale to predict complications of preeclampsia in pregnant women diagnosed with preeclampsia who were admitted to the obstetrics and gynecology department of a referral hospital, from October 2021 to December 2022.</p><p><strong>Materials and methods.: </strong>This was a retrospective cohort design study. Data was collected from the medical records of patients diagnosed with preeclampsia, and both scales (RFSPC and fullPIERS) were applied. With these results, the sensitivity, specificity and the area under the ROC curve (AUC) were obtained by taking different cut-off points. The best score was selected as the one with the highest AUC. The differences between the scales were explored by comparing their AUCs.</p><p><strong>Results.: </strong>We included 367 pregnant women. The RFSPC had a sensitivity of 71%, a specificity of 73% and an AUC of 0.722 with a cutoff point of 3 points. Whereas the fullPIERS scale showed 76%, 84% and 0.804 respectively with a cutoff point of 0.75%.</p><p><strong>Conclusions.: </strong>Both scales can be useful for identifying pregnant women at risk of complications with cutoff points different from those defined internationally.</p>","PeriodicalId":53651,"journal":{"name":"Revista Peruana de Medicina de Experimental y Salud Publica","volume":"42 1","pages":"46-53"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Peruana de Medicina de Experimental y Salud Publica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17843/rpmesp.2025.421.14041","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives.: To evaluate the ability of the Risk Factor Scale for Preeclampsia Complications (RFSPC) and the fullPIERS (Pre-eclampsia Integrated Estimate of RiSk) scale to predict complications of preeclampsia in pregnant women diagnosed with preeclampsia who were admitted to the obstetrics and gynecology department of a referral hospital, from October 2021 to December 2022.
Materials and methods.: This was a retrospective cohort design study. Data was collected from the medical records of patients diagnosed with preeclampsia, and both scales (RFSPC and fullPIERS) were applied. With these results, the sensitivity, specificity and the area under the ROC curve (AUC) were obtained by taking different cut-off points. The best score was selected as the one with the highest AUC. The differences between the scales were explored by comparing their AUCs.
Results.: We included 367 pregnant women. The RFSPC had a sensitivity of 71%, a specificity of 73% and an AUC of 0.722 with a cutoff point of 3 points. Whereas the fullPIERS scale showed 76%, 84% and 0.804 respectively with a cutoff point of 0.75%.
Conclusions.: Both scales can be useful for identifying pregnant women at risk of complications with cutoff points different from those defined internationally.
期刊介绍:
La Revista Peruana de Medicina Experimental y Salud Pública (RPMESP) es el órgano oficial de difusión científica del Instituto Nacional de Salud (INS) del Perú. Es una publicación arbitrada por pares, de periodicidad trimestral, de ámbito y difusión mundial, indizada en MEDLINE/Index Medicos, SCOPUS, EMBASE, SciELO Salud Pública y otras bases de datos internacionales. La RPMESP es distribuida en su versión impresa y electrónica, con acceso gratuito a texto completo. La RPMESP publica artículos referidos a temas del ámbito biomédico y de salud pública, resaltando aportes prácticos, que contribuyan a mejorar la situación de salud del país y de la región. Propicia el intercambio de la experiencia científica en salud entre instituciones y personas dedicadas a la investigación dentro y fuera del Perú a fin de promover el avance y la aplicación de la investigación en salud.